Cargando…
Oral Contraceptive Pills Are an Effective Method of Preventing Pregnancy in Women With Crohn’s Disease
BACKGROUND: Oral contraceptive pill (OCP) use in the general population is associated with a failure rate as low as 0.3% with perfect use but as high as 9% with typical use. Women with Crohn’s disease (CD) may have malabsorption in the setting of small bowel disease or resection, which could affect...
Autores principales: | Daoud, Nader D, Ghoz, Hassan, Cannon, Rachel, Farraye, Jennifer A, Picco, Michael F, Kane, Sunanda V, Kochhar, Gursimran S, Woodhams, Elisabeth J, Farraye, Francis A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802294/ https://www.ncbi.nlm.nih.gov/pubmed/36777546 http://dx.doi.org/10.1093/crocol/otab078 |
Ejemplares similares
-
Efficacy of a two-dose hepatitis B vaccination with a novel immunostimulatory sequence adjuvant (Heplisav-B) on patients with chronic liver disease: a retrospective study
por: Kwon, Joshua Y., et al.
Publicado: (2023) -
Time to Flexible Sigmoidoscopy or Colonoscopy in Patients Admitted With Ulcerative Colitis Has Decreased From 2012 to 2018
por: Bali, Aman S, et al.
Publicado: (2021) -
Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in Patients With Inflammatory Bowel Disease: A Propensity-Matched Study
por: Hashash, Jana G., et al.
Publicado: (2023) -
Tixagevimab and Cilgavimab (Evusheld) as Pre-exposure Prophylaxis for COVID-19 in Patients With Inflammatory Bowel Disease: A Propensity Matched Cohort Study
por: Desai, Aakash, et al.
Publicado: (2023) -
The Immunogenicity of the Influenza, Pneumococcal, and Hepatitis B Vaccines in Patients With Inflammatory Bowel Disease Treated With Vedolizumab
por: Harrington, Jill E, et al.
Publicado: (2020)